MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Drug Interactions »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Industry < Drug Interactions < Drug Labeling  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000689 (2018) Stefano Bellosta [Italie] ; Alberto Corsini [Italie]Statin drug interactions and related adverse reactions: an update.
000704 (2018) Eric G. Boyce [États-Unis] ; Edward L. Rogan [États-Unis] ; Deepti Vyas [États-Unis] ; Neel Prasad [États-Unis] ; Yvonne Mai [États-Unis]Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis.
000B74 (2017) Amélie Moreau [France] ; Marc Le Vée [France] ; Elodie Jouan [France] ; Claire Denizot [France] ; Yannick Parmentier [France] ; Olivier Fardel [France]Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.
000B79 (2017) Eun Bong Lee [Corée du Sud] ; Nikki Daskalakis [États-Unis] ; Christine Xu [États-Unis] ; Anne Paccaly [États-Unis] ; Barry Miller [États-Unis] ; Roy Fleischmann [États-Unis] ; Inga Bodrug [Allemagne] ; Alan Kivitz [États-Unis]Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis.
000D14 (2016) B. Clarivet [France] ; P. Robin [France] ; Y M Pers [France] ; R. Ferreira [France] ; J. Lebrun [France] ; C. Jorgensen [France] ; D. Hillaire-Buys [France] ; V. Brés [France] ; J L Faillie [France]Tocilizumab and mesenteric arterial thrombosis: drug-drug interaction with anticoagulants metabolized by CYP 450 and/or by P-glycoprotein.
000D87 (2016) Nicola Ferri [Italie] ; Stefano Bellosta [Italie] ; Ludovico Baldessin [Italie] ; Donatella Boccia [Italie] ; Giorgi Racagni [Italie] ; Alberto Corsini [Italie]Pharmacokinetics interactions of monoclonal antibodies.
000E04 (2016) Thomas J. Long [États-Unis] ; Patrick A. Cosgrove [États-Unis] ; Robert T. Dunn [États-Unis] ; Donna B. Stolz [États-Unis] ; Hisham Hamadeh [États-Unis] ; Cynthia Afshari [États-Unis] ; Helen Mcbride [États-Unis] ; Linda G. Griffith [États-Unis]Modeling Therapeutic Antibody-Small Molecule Drug-Drug Interactions Using a Three-Dimensional Perfusable Human Liver Coculture Platform.
001416 (2014) Xiaoping Zhang ; Lucy Rowell ; Scott Fettner ; Carol Lau ; Denise TeuberAssessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis.
001462 (2013) James E. Frampton [Oman]Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis.
001546 (2013) Peter N. Morcos [États-Unis] ; Xiaoping Zhang ; Christine Mcintyre ; Beate Bittner ; Lucy Rowell ; Zubair HussainPharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20.
001672 (2012) Christophe Schmitt [Suisse] ; Barbara Kuhn ; Xiaoping Zhang ; Alan Kivitz ; Susan GrangeTocilizumab has no clinically relevant effects on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
001694 (2012) Iris Navarro-Millán [États-Unis] ; Jasvinder A. Singh ; Jeffrey R. CurtisSystematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.
001721 (2012) Masaki Shimizu [Japon] ; Kazuyuki Ueno ; Akihiro YachieRelapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab.
001754 (2012) Sooha Kim [Royaume-Uni] ; Andrew J K. Östör ; Muhammad K. NisarInterleukin-6 and cytochrome-P450, reason for concern?
001919 (2011) C. Schmitt [Suisse] ; B. Kuhn ; X. Zhang ; A J Kivitz ; S. GrangeDisease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis.
001985 (2010) Tocilizumab (Actemra) for rheumatoid arthritis.
001A65 (2009) Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
001B78 (2007) Cécile Fournel ; Mehdi Medjoub ; Samuel Limat ; Marie-Christine Woronoff-Lemsi[2/2 The other biotherapies].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Drug Interactions" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Drug Interactions" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Interactions
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021